172 related articles for article (PubMed ID: 34207689)
1. Elevated Procalcitonin Is Positively Associated with the Severity of COVID-19: A Meta-Analysis Based on 10 Cohort Studies.
Shen Y; Cheng C; Zheng X; Jin Y; Duan G; Chen M; Chen S
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34207689
[No Abstract] [Full Text] [Related]
2. The Level of Procalcitonin in Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
Heidari-Beni F; Vahedian-Azimi A; Shojaei S; Rahimi-Bashar F; Shahriary A; Johnston TP; Sahebkar A
Adv Exp Med Biol; 2021; 1321():277-286. PubMed ID: 33656733
[TBL] [Abstract][Full Text] [Related]
3. The Association of Asthma With COVID-19 Mortality: An Updated Meta-Analysis Based on Adjusted Effect Estimates.
Hou H; Xu J; Li Y; Wang Y; Yang H
J Allergy Clin Immunol Pract; 2021 Nov; 9(11):3944-3968.e5. PubMed ID: 34464749
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin Has Good Accuracy for Prognosis of Critical Condition and Mortality in COVID-19: A Diagnostic Test Accuracy Systematic Review and Meta-analysis.
Zare ME; Wang Y; Nasir Kansestani A; Almasi A; Zhang J
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):557-569. PubMed ID: 33463126
[TBL] [Abstract][Full Text] [Related]
5. Elevated interleukin-6 and adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates.
Zhang P; Shi L; Xu J; Wang Y; Yang H
Immunogenetics; 2020 Oct; 72(8):431-437. PubMed ID: 33067641
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin and secondary bacterial infections in COVID-19: association with disease severity and outcomes.
Vazzana N; Dipaola F; Ognibene S
Acta Clin Belg; 2022 Apr; 77(2):268-272. PubMed ID: 32966166
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of procalcitonin in cancer patients with coronavirus disease 2019.
Tiutan T; Wallins JS; Brown S; Gonen M; Korenstein D
Clin Chem Lab Med; 2023 Jan; 61(2):339-348. PubMed ID: 36367353
[TBL] [Abstract][Full Text] [Related]
8. Predictive values of procalcitonin for coinfections in patients with COVID-19: a systematic review and meta-analysis.
Wei S; Wang L; Lin L; Liu X
Virol J; 2023 May; 20(1):92. PubMed ID: 37158904
[TBL] [Abstract][Full Text] [Related]
9. The role of procalcitonin in predicting risk of mechanical ventilation and mortality among moderate to severe COVID-19 patients.
Twe CW; Khoo DKY; Law KB; Ahmad Nordin NSB; Sathasivan S; Lim KC; Atikah SK; Syed Badaruddin SNAB; Chidambaram SK
BMC Infect Dis; 2022 Apr; 22(1):378. PubMed ID: 35428273
[TBL] [Abstract][Full Text] [Related]
10. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin as a Prognostic Factor in Patients with COVID-19 in Southwestern Iran.
Abadi MSS; Taheri E; Raesi A; Arjmand MH; Kheirii S; Shahinfard N; Habibi Z
Infect Disord Drug Targets; 2022; 22(3):e070122200097. PubMed ID: 34994319
[TBL] [Abstract][Full Text] [Related]
12. Interstitial lung disease independently associated with higher risk for COVID-19 severity and mortality: A meta-analysis of adjusted effect estimates.
Wang Y; Hao Y; Hu M; Wang Y; Yang H
Int Immunopharmacol; 2022 Oct; 111():109088. PubMed ID: 35921779
[TBL] [Abstract][Full Text] [Related]
13. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
Zinellu A; Mangoni AA
Front Immunol; 2021; 12():696085. PubMed ID: 34163491
[TBL] [Abstract][Full Text] [Related]
14. Severe and fatal COVID-19 is characterised by increased circulating glucagon like peptide 1 and procalcitonin modulated by type 2 diabetes.
Bloch O; Kobi P; Ben Shimol A; Rotmensh A; Kagansky D; Zelnik-Yovel D; Yehudah GB; Cantrell D; Rapoport MJ
Diabetes Metab Res Rev; 2023 Sep; 39(6):e3635. PubMed ID: 36960549
[TBL] [Abstract][Full Text] [Related]
15. Association of inflammatory markers with the severity of COVID-19: A meta-analysis.
Zeng F; Huang Y; Guo Y; Yin M; Chen X; Xiao L; Deng G
Int J Infect Dis; 2020 Jul; 96():467-474. PubMed ID: 32425643
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of cardiac markers for predictive factors on severity and mortality of COVID-19.
Wungu CDK; Khaerunnisa S; Putri EAC; Hidayati HB; Qurnianingsih E; Lukitasari L; Humairah I; Soetjipto
Int J Infect Dis; 2021 Apr; 105():551-559. PubMed ID: 33711519
[TBL] [Abstract][Full Text] [Related]
17. The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates.
Li S; Ren J; Hou H; Han X; Xu J; Duan G; Wang Y; Yang H
Neurol Sci; 2022 Jul; 43(7):4049-4059. PubMed ID: 35325320
[TBL] [Abstract][Full Text] [Related]
18. Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or "just" a marker of bacterial coinfection?
Lugito NPH
Curr Res Transl Med; 2021 May; 69(2):103289. PubMed ID: 33845428
[TBL] [Abstract][Full Text] [Related]
19. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
[TBL] [Abstract][Full Text] [Related]
20. Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study.
Atallah NJ; Warren HM; Roberts MB; Elshaboury RH; Bidell MR; Gandhi RG; Adamsick M; Ibrahim MK; Sood R; Bou Zein Eddine S; Cobler-Lichter MJ; Alexander NJ; Timmer KD; Atallah CJ; Viens AL; Panossian VS; Scherer AK; Proctor T; Smartt S; Letourneau AR; Paras ML; Johannes S; Wiemer J; Mansour MK
PLoS One; 2022; 17(1):e0262342. PubMed ID: 35025929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
